Evaluation of the Effects of Galantamine on Cardiac Function in Elderly Patients With Alzheimer's Disease

IŞIK A. T., Bozoglu E., Naharci I., Kilic S.

AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY, cilt.8, sa.5, ss.454-459, 2010 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 8 Sayı: 5
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1016/j.amjopharm.2010.09.001
  • Dergi Adı: AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.454-459
  • Anahtar Kelimeler: galantamine, elderly, Alzheimer's disease, electrocardiography
  • Dokuz Eylül Üniversitesi Adresli: Hayır

Özet

Background: Galantamine, a cholinesterase inhibitor, is used as a first-line drug in the treatment of Alzheimer's disease (AD). However, it may have vagotonic effects, which may cause bradycardia and/or heart block in patients with or without a history of cardiac disease.